Johnson & Johnson Chairman and CEO Alex Gorsky comments on J&J's recently announced executive changes as the health-care giant prepares for its CEO and top scientist to depart. He speaks during an interview with Bloomberg's David Westin on "Bloomberg Markets." Mathai Mammen, head of research and development for the Janssen pharmaceutical unit, and Bill Hait, global head of external innovation, will be elevated to executive vice president roles.